Page last updated: 2024-11-05

ethyl n-alpha-acetyl-tyrosinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl N-alpha-acetyl-tyrosinate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethyl N-acetyl-L-tyrosinate : An L-tyrosine derivative that is the ethyl ester of N-acetyltyrosine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13289
CHEMBL ID3278820
CHEBI ID28828
SCHEMBL ID468756
MeSH IDM0050981

Synonyms (40)

Synonym
nsc 87506
nsc 64725
tyrosine, n-acetyl-, ethyl ester, l-
einecs 212-663-5
CHEBI:28828 ,
ethyl n-acetyl-l-tyrosinate
ac-tyr-oet
840-97-1
n-acetyl-l-tyrosine ethyl ester
ethyl n-alpha-acetyl-tyrosinate
C01657
A0118 ,
ethyl (2s)-2-acetamido-3-(4-hydroxyphenyl)propanoate
l-tyrosine, n-acetyl-, ethyl ester
CHEMBL3278820
SKAWDTAMLOJQNK-LBPRGKRZSA-N
n-acetyl tyrosine ethylester
n-acetyl tyrosine ethyl ester
SCHEMBL468756
AKOS016844077
(s)-ethyl 2-acetamido-3-(4-hydroxyphenyl)propanoate
n-acetyl-l-tyrosineethylestermonohydrate
n-acetyltyrosine ethyl ester monohydrate
W-106602
l-tyrosine, n-acetyl-, ethyl ester, hydrate (1:1)
l-tyrosine, n-acetyl-, ethyl ester, monohydrate
mfcd00002389
ethyl n-acetyl-l-tyrosinate (ac-l-tyr-oet)
AS-68931
l-atee
Q27103918
ac-tyr.oet
AMY25349
D87592
DTXSID20877256
(s)-ethyl2-acetamido-3-(4-hydroxyphenyl)propanoate
CS-0298722
ethyl acetyl-l-tyrosinate
EN300-302678
HY-W236261
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
L-tyrosine derivativeA proteinogenic amino acid derivative resulting from reaction of L-tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-tyrosine by a heteroatom.
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
acetamidesCompounds with the general formula RNHC(=O)CH3.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1149947Binding affinity to chymotrypsin (unknown origin) assessed as acetylation at pH 71977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID1149943Binding affinity to chymotrypsin (unknown origin) assessed as hydrolysis1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID1149944Binding affinity to chymotrypsin (unknown origin)1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID1149948Binding affinity to chymotrypsin (unknown origin) assessed as deacetylation1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (64.44)18.7374
1990's11 (24.44)18.2507
2000's4 (8.89)29.6817
2010's1 (2.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.10 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index3.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]